Positive Results From Enzyme-Augmented Insulin Pump Trial

[Northerner]

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced positive results from a study in patients with type 1 diabetes that receive their insulin therapy via pumps. The Phase 1b study was conducted as a randomized, double-blind, crossover design, to determine insulin pharmacokinetics, glucodynamics, safety and tolerability of rHuPH20 (recombinant human hyaluronidase) as a single injection prior to the start of three days of NovoLog? insulin aspart pump infusion therapy. The data demonstrated that pre-administration of 150 units of rHuPH20 (approximately 1.3 micrograms of enzyme) led to consistent insulin exposure over the infusion set life and superior glucose control following meals.

http://www.prnewswire.com/news-rele...e-augmented-insulin-pump-trial-132747293.html

 

[trophywench]

This sounds brilliant, doesn't it?

Should certainly help those on large amounts of insulin even if it doesn't help anyone on an eyeful.